The drug is already being studied in a Phase 3 Health Canada approved clinical trial for advanced cancer pain.
The six-month study will be led by Gold Coast Neurologist, Dr. Arman Sabet who has been involved in many international clinical trials specializing in neuromuscular disorders and stroke.
Deciphering the ways cannabis acts in the body to alter appetite could lead to new treatments for illness-induced anorexia common in cancer, HIV/AIDS, heart disease, and some metabolic disorders.
To date, the only cure for SCD is a bone marrow transplant, which is costly and out of reach for most patients.
Researchers at ebbu are using human clinical studies to track and record how different strains affect different patients to help users find the cannabis product they want and need.
An Australian study of medicinal cannabis used to treat childhood epilepsy has found most samples contained some THC and little CBD, contrary to parents' expectations.
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.
While cannabis hasn’t been shown to cure cancer on its own, despite the pervasiveness of anecdotal stories, scientists have found that cannabinoids have anti-cancer properties that could be helpful in drug development.
A majority of Australian GPs support medicinal cannabis being available on prescription, with their preferred "access model" involving trained GPs prescribing independently of specialists.